<DOC>
	<DOCNO>NCT00680680</DOCNO>
	<brief_summary>To determine whether addition dual Five Alpha Reductase Inhitor ( Dutasteride ) alleviate urinary retention secondary BPH fail void trial without catheter . Following treatment Alpha Blocker alone .</brief_summary>
	<brief_title>Treatment Refractory Urinary Retention Secondary Benign Prostatic Hyperplasia ( BPH ) With Dual Five Alpha Reductase Inhibition Combined With Alpha Blocker</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Urinary Retention</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<criteria>1 . Males betewen age 50 90 year age.Written inform consent . 2 . Men acute urinary retention attribute bladder outlet obstruction cause BPH , fail atleast 1 week trial alpha blocker treatment . 3 . PSA level equal great 1.5ng/ml equal less 15 ng/ml . 1 . Urinary retention attribute neurogenic myogenic bladder dysfunction . 2 . Use psychotrophic medication . 3 . Use antichollinergic medication . 4 . Prostate cancer . 5 . Allery five alpha reductase inhibitor . 6 . Prior prostate surgery . 7 . Urethral stricture . 8 . Bladder calculus . 9 . Invasive bladder cancer . 10 . Inability understand agree requirement study . 11 . Any investigational drug receive within 30 day prior study entry .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Urinary retention secondary benign prostatic hyperplasia</keyword>
</DOC>